Processa Pharmaceuticals (PCSA) reported that it completed the enrollment and dosing of the 20 patients required for the planned formal interim ...

Interim safety and efficacy data to be reported in Q1VERO BEACH, Fla., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Processa ...

BAKERSFIELD, CA – December 26, 2025 – PRESSADVANTAGE – 911 Restoration of Bakersfield announces the expansion of its ...

Coventry, UK – December 26, 2025 – PRESSADVANTAGE – Strongway Gym Supplies has put its home multi-gym on sale. It is aimed at ...

HONG KONG, HK – December 26, 2025 – PRESSADVANTAGE – Ginza Diamond Shiraishi Hong Kong has released an announcement outlining ...

NEW YORK, NY / ACCESS Newswire / December 26, 2025 / Public-market capital raises are often interpreted through a narrow lens, especially in the small-cap universe. They are frequently treated as ...

Conifer, Colorado – December 26, 2025 – PRESSADVANTAGE – Best Awning Company, a Denver-based shade solutions provider serving ...

ORLANDO, FL / ACCESS Newswire / December 26, 2025 / RedChip Companies will air interviews with Processa Pharmaceuticals, Inc.

Protecting Homes and Businesses with Expert Roof Repairs, Replacements, and Storm Damage Solutions in Ladue Saint Peters, ...

Chantilly, VA – December 26, 2025 – PRESSADVANTAGE – NextDAY Cabinets Chantilly Showroom has announced a strategic partnership with Kith Kitchen, expanding its wholesale cabinet offerings to better ...

The average one-year price target for Processa Pharmaceuticals (NasdaqCM:PCSA) has been revised to $25.50 / share. This is an increase of 2,400.00% from the prior estimate of $1.02 dated December 3, ...